Almitrine Bismesylate + Raubasine
Indications
This tablet is indicated for the reduction of neurological damage and faster recovery after a cerebral stroke, minor age-related neurological disorders, some visual disorders related to the circulation, and some circulation-related disorders of the inner ear (hearing loss, dizziness, buzzing sounds in the ear).
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Almitrine Bismesylate & Raubasine combines raubasine, a vasodilator, and almitrine, a respiratory stimulant. Raubasine has an adrenolytic activity that is predominantly related to a post-synaptic blocking effect. Furthermore, under conditions of cerebral hypoxia, almitrine causes an increase in the partial pressure of oxygen in arterial blood (Pa02); almitrine causes an increase in the Pa02 and an increase in the oxygen saturation in arterial blood (Sa02), without modifying ventilatory parameters.
Pregnancy & Breastfeeding
Pregnancy is not advised for this medicine. If a doctor decides it is truly necessary, it should be used cautiously and only when the potential benefit to the mother clearly outweighs the possible risk to the unborn baby.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.